pharma news today glp-1 2025 marked a breakout year for weight-loss & drugs in India, with Mounjaro, Wegovy & Ozempic entering the market & Mounjaro emerging as the clear leader. As the semaglutide patent expiries GLP-1 Shortage = Over -

6-Thioguanine nucleotide-adapted azathioprine therapy does not lead to higher remission rates than standard therapy in chronic active Crohn disease: results from a randomized, controlled, open trial

Remember that its essential to consult a dermatologist or healthcare professional if youre concerned about any skin issues, as they can provide personalized guidance and treatment options

Search strategy and study selection We conducted a comprehensive systematic search across five electronic databases: PubMed, Embase, Web of Science, Scopus, and the Cochrane Library, as well as the Google Scholar search engine, from inception to September 30, 2025, to identify studies investigating the association between GLP-1 receptor agonists and AUD outcomes

People who can benefit from B12 injections include: Older adults